Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. - Wikidata - wikimedia - TriplyDB

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

http://www.wikidata.org/entity/Q43761430

about

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2 '-deoxycytidine Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment Epigenetics as a mechanism driving polygenic clinical drug resistance Targeting caspases in cancer therapeutics Oncolytic Sendai virus-based virotherapy for cancer: recent advances The role of CD95 and CD95 ligand in cancer Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma Current treatment for Ewing's sarcoma Epigenetic effects of cadmium in cancer: focus on melanoma Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis.Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies Pediatric oncology.Microarray-based DNA methylation study of Ewing's sarcoma of the bone.TRAIL in cancer therapy: present and future challenges.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity Aberrant DNA methylation in malignant melanoma The use of selected nutrition supplements and complementary and alternative medicine in liver disease.Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.Copy Number Alterations and Methylation in Ewing's Sarcoma.Chromatin modification, leukaemia and implications for therapy.Targeting cell death in tumors by activating caspases.Oncolytic adenoviruses: A thorny path to glioma cure Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells Cellular FLICE-inhibitory protein: an attractive therapeutic target?Targeting AML through DR4 with a novel variant of rhTRAIL Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion DNA methylation in haematological malignancies: the role of decitabine.Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy.Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy.Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma.Mechanisms of resistance to TRAIL-induced apoptosis in cancer.

P2860

Q21261286-6D547F24-A075-4051-A4F1-DD5A1EA980A9 Q24170503-2DD01849-DB17-4E8A-A018-9DA44955775A Q24319929-FAB9A9DA-0EC9-4497-8BC2-021235608655 Q24651640-4864A6CB-970A-41D0-A581-8AFAC20230C3 Q26821986-AA6391C1-138B-452B-9663-8892A4D9C590 Q26825239-75B357FE-55A3-43B9-861E-A1594DFC960D Q26995847-052C5E05-F40E-4346-85B2-9499B8DE5A12 Q27853200-05670387-74CB-4769-B239-39782763C2A3 Q28248896-0EB70732-3618-4665-BD64-53F3A3A94CA9 Q28386972-0E16297C-485B-40EC-8F58-CC36BA07A7D0 Q28391040-9786BA2B-9395-4711-82C1-B208F8DFCA44 Q30479062-C190833F-584F-40B5-9ED2-99015F12F47C Q33186742-EF6F93F9-387E-4788-ACA4-8D4E21BE8707 Q33344484-5D0D6D9C-DE92-4D70-A90A-1BE0E2F8AE1C Q33390459-270344B2-CF5F-4006-A4CF-ACF1AD70F2E7 Q33829218-6694C08F-37AB-41CA-8326-336D45121094 Q33980682-F327C028-6057-4D99-A02E-2F52FFEC6B13 Q34038452-2D8F5C3F-7E2A-4285-AD8F-AB8E12546BC2 Q34141451-1C3A097B-3E31-4AD4-BFDF-5D39F03954DE Q34291312-8F26DDC4-5874-45F9-AC10-B5B6B047DC64 Q34405013-8B2450AF-6DD7-4B72-ADB7-3C33A101DCC8 Q34416282-7F8EA3C9-2F1E-4318-B98D-980946A433A6 Q34516587-D4B4B425-42B9-4DF4-BC18-64BDD72FD4D1 Q34554574-E33E4755-4956-4133-B4EE-B518EE8C11A0 Q34600157-1FA0BC97-295E-4859-B2A4-3548DEDD7766 Q34631306-6ED8BDFD-3AEA-45E7-92BF-EEA82833D41F Q34700651-5828E764-A5C0-4A25-9BE2-A7ECCFC29217 Q34786248-8F93412B-F253-41B4-924B-077D1CE7C0D7 Q35058822-BBECDD09-9298-48D3-8D19-B8A6A1E84295 Q35077747-78A17903-44A1-4F6C-BFFC-92F77B6E0491 Q35117949-F0F92EE4-8F65-467D-8CEC-05412847D0D8 Q35186676-7FF4CF79-EBE5-454B-9729-38601302AE0E Q35377418-5DEAF2E2-01B4-4AE8-A790-3ABDD12E87ED Q35480734-54DD2F37-53B0-4605-B54E-06FC0ABD9CB4 Q35594048-C0F95BF2-B044-47EF-833B-08C48E717BFE Q35823413-48E2FCB6-E3AE-4794-AB3C-783D7EC91E09 Q35855534-222B1584-E966-4015-AB28-B85D52C000BA Q35935802-CB7768F5-1499-4917-9CDE-4EC6E58B485E Q35936863-3355F7A3-658E-4BF3-80E7-979D1FCFE785 Q35954258-AEB4E748-38C0-41E0-BD40-9122022BECDA

P2860

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

http://www.wikidata.org/entity/Q43761430

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Sensitization for death recept ...... emethylation or gene transfer.

@en

Sensitization for death recept ...... emethylation or gene transfer.

@nl

type

label

Sensitization for death recept ...... emethylation or gene transfer.

@en

Sensitization for death recept ...... emethylation or gene transfer.

@nl

prefLabel

Sensitization for death recept ...... emethylation or gene transfer.

@en

Sensitization for death recept ...... emethylation or gene transfer.

@nl

P1433

Q43761430-A2C1744C-34F7-4B81-AD6E-3E0D07475D61

P1476

Q43761430-54FB3076-860F-4C0B-B04F-EF421A39A02E

P2093

Q43761430-3DCA808C-FA42-43C4-A694-E2BCC2AF966E

Q43761430-6E0DCEDB-F971-425B-8578-785F0E618DDE

Q43761430-8583B52D-BC5B-4F30-B01B-737F9EBDA8E1

Q43761430-CE868580-D785-41E2-A2D5-39B6025102B5

P2860

Q43761430-0ACAF37E-7DDB-41B5-8DE0-580774E5311C

Q43761430-0C2E6EF2-68C2-4C95-92C5-5F5C0BADBBD2

Q43761430-151328CD-35E4-4441-81E6-3CCFD791E550

Q43761430-1D31EA45-8F3B-4068-8ACE-C70B420940DB

Q43761430-282293D4-73C4-4683-A5A8-5AE6BE56C55F

Q43761430-2A7A153C-B2CC-472C-9A95-BD154F6D5763

Q43761430-2C561588-1262-4169-A809-28076CDBC49D

Q43761430-2D4EDD59-F7F5-4B42-92E0-420F47175A03

Q43761430-322076BE-BE0B-48F7-80C0-E40E39CB5FD3

Q43761430-3C81497F-E18E-444F-8469-8702A4A64C04

P2888

Q43761430-436D108D-91C9-492A-AFA9-AD27ADB66C1C

P304

Q43761430-BDAFD990-3D53-4D92-BB3D-405233237555

P31

Q43761430-CDAD0B3A-BE1C-4987-9264-0DD59E482823

P356

Q43761430-D945780A-19CD-45C5-90A8-FE46C5AFE8ED

P407

Q43761430-E21C609B-7E6D-4B40-9943-C810A10C3CAD

P433

Q43761430-05403B9B-7B6A-4608-A64B-2693E246BF55

P478

Q43761430-58275636-0810-452E-957F-F2128CACD774

P50

Q43761430-3C405D98-3CDC-419A-AA96-7388892C4F74

Q43761430-DF05BB02-CF06-4A4F-85EC-A4CF81AA3AC3

P577

Q43761430-464F5F05-1157-4F83-AB03-1A73E6CA0B5E

P5875

Q43761430-CF031458-4FC1-4E6B-A977-381F416CC3DB

P6179

Q43761430-A8E86DB4-0DD9-4A5C-BED0-1E55294AEB94

P698

Q43761430-47709C34-6681-441C-82BC-66CDF3899EFF

P356

P1433

P1476

Sensitization for death recept ...... emethylation or gene transfer.

@en

P2093

B Dockhorn-Dworniczak

http://www.w3.org/2001/XMLSchema#string

E Meyer

http://www.w3.org/2001/XMLSchema#string

F van Valen

http://www.w3.org/2001/XMLSchema#string

M U Küfer

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization of mitochondrial apoptosis-inducing factor

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Mitochondrial release of caspase-2 and -9 during the apoptotic process

Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

P2888

P304

5865-5877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1204750

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Klaus-Michael Debatin

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11757349

http://www.w3.org/2001/XMLSchema#string

P6179

1022567684

http://www.w3.org/2001/XMLSchema#string

P698

11593392

http://www.w3.org/2001/XMLSchema#string